Founded in 2015, Kezar Life Sciences is a privately held biotech company based in South San Francisco. They are dedicated to discovering and developing innovative treatments for immune-mediated and oncologic disorders. Their pipeline includes product candidates such as KZR-616 and a protein secretion program. With a strong belief in the synergies between protein degradation and protein secretion, Kezar aims to revolutionize the treatment of autoimmune disorders and address unmet needs in the field of cancer therapeutics.